Exclusive: Malaysia's A-Bio invests $1.8m in pathology service provider Clinipath

Exclusive: Malaysia's A-Bio invests $1.8m in pathology service provider Clinipath

Photo: Bloomberg

A-Bio, a strategic investment firm established by the Malaysian government, has invested RM7 million ($1.8 million) in Clinipath Malaysia, one of the country’s leading pathology service providers.

Clinipath, wholly owned by Malaysian Genomics Resource Centre, said the investment by A-Bio will help it improve its IT infrastructure, expand laboratories in key locations, and develop new clinical tests.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter